Gujarat Themis Biosyn's Stock Reaches All-Time High, Outperforms Sector and Sensex

Gujarat Themis Biosyn, a smallcap pharmaceutical company, has recently seen a surge in its stock price, reaching an all-time high on June 20, 2024. The stock has been performing well in the market, with a 'Hold' call from MarketsMOJO. On June 20, the stock hit a new 52-week high of Rs.505, outperforming the sector by 0.92%. It has also shown a consecutive gain for the last 3 days, with a 8.73% increase in returns during this period. Additionally, the stock is currently trading higher than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. In the past year, Gujarat Themis Biosyn has shown an impressive performance of 214.14%, while the Sensex has only seen a 21.95% increase. This showcases the company's strong growth and potential in the pharmaceutical industry. Gujarat Themis Biosyn is a smallcap company in the pharma sector, and its recent stock performance reflects its success and growth in the market. With a 'Hold' call from MarketsMOJO, investors can keep an eye on this company for potential opportunities in the future.